Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has announced that the Company’s Chairman, Cathal Friel, will be attending the HC Wainwright Global Investment Conference, which is taking place from 12-14 September at the Lotte New York Palace Hotel in New York City, NY, USA.

AI-driven biotech breakthroughs power Poolbeg Pharma
Poolbeg Pharma is a cutting-edge biotech company with high-value therapeutic programmes and AI-led drug discovery, appealing to forward-thinking investors.